Emmanuel Scotet

4PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 28, 2024
Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents.

Lola Boutin, Clément Barjon, Morgane Chauvet

|Oct 20, 2021
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response.

Aude De Gassart, Kieu-Suong Le, Patrick Brune

|Apr 03, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model.

Marisa Capitao, Justine Perrin, Sylvain Simon

|Sep 23, 2020
Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors.

Chirine Rafia, Christelle Harly, Emmanuel Scotet

Pageof 1

Frequent Collaborators

1 joint publications

Chirine Rafia

1 joint publications

Christelle Harly

1 joint publications

Sébastien Gouard

1 joint publications

Nicolas Chouin